SCHEMBL19953977

SCHEMBL19953977

Cc1ccc(/C=C2\CN(C(=O)[C@@H](N)Cc3ccccc3)C/C(=C\c3ccc([N+](=O)[O-])cc3)C2=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.52
HDAC8 Q9BY41 5/20 0.47
ACHE P22303 5/20 0.45
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
MDM2 Q00987 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
USP18 Q9UMW8 2/20 0.42
UCHL5 Q9Y5K5 2/20 0.42
MMP2 P08253 1/20 0.41
HSP90AA1 P07900 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17693740 0.95 CASP3 (0.56) CASP3HDAC8ACHEMAPTMEN1
SCHEMBL17693764 0.87 CASP3 (0.48) CASP3HDAC8ACHEMAPTALDH1A1
SCHEMBL19954694 0.84 HDAC8 (0.63) HDAC8ACHEMAPTMEN1ALDH1A1
SCHEMBL17693760 0.83 CASP3 (0.53) CASP3ACHEMAPTMEN1ALDH1A1
Hydrochloric Acid SCHEMBL23877810 0.82 HDAC8 (0.64) HDAC8ACHEMAPTMEN1ALDH1A1
SCHEMBL25004153 0.81 DPP4 (0.44) CASP3HDAC8MAPTRAB9AUSP18
SCHEMBL25004554 0.81 DPP4 (0.44) CASP3HDAC8MAPTRAB9AUSP18
SCHEMBL25003481 0.78 CASP3 (0.50) CASP3ACHEMAPTMEN1RAB9A
SCHEMBL19954682 0.78 CASP3 (0.50) CASP3ACHEMAPTMEN1ALDH1A1
SCHEMBL17693738 0.78 CASP3 (0.58) CASP3ACHEMAPTRAB9AUSP18

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9913834-B2 Bis-benzylidine piperidone proteasome inhibitor with anticancer activity THE JOHNS HOPKINS UNIVERSITY (US) 2018-03-13 US disclosed